Wild-type HBV dependently replicating HBV shRNA vectors are proposed as self-renewing, self-limiting anti-HBV RNAi agents.
Optimized HBV vectors encoding two shRNAs replicated in vitro when complemented by HBV helper or wild-type HBV constructs.
HBV vectors efficiently silenced a model target as well as wild-type HBV antigen production and replication in vitro.
HBV shRNA vectors delivered into HBV transgenic mice by an adenovirus shuttle significantly reduced serum HBsAg and HBV load.
Vector treated mice produced progeny vector particles but proving spread will require a small animal infection model.